Skip to main content

Table 1 Characteristics of DEPDC5 and NPRL3 participants

From: Neurophysiological assessment of cortical activity in DEPDC5- and NPRL3-related epileptic mTORopathies

ID

Sex

Age (years)

Medication (mg/day)

DEPDC5_01

F

33

ESL (400), CLB (10), LTG (150)

DEPDC5_02

F

48

None

DEPDC5_03

F

68

None

NPRL3_01

F

39

None

NPRL3_02

M

12

None

NPRL3_03

F

14

CBZ (400)

NPRL3_04

F

16

CBZ (1200); CLB (1)

NPRL3_05

F

36

None

  1. CBZ Carbamazepine, CLB Clobazam, ESL Eslicarbazepine acetate, LTG Lamotrigine